Form 4: MIMEDX Director Dorothy Puhy Receives Annual Restricted Stock Grant

MIMEDX Group, Inc. Director Dorothy Puhy was granted 28,609 shares of common stock as part of her annual restricted stock compensation, effective June 18, 2025.

Summary

• Dorothy E. Puhy, a Director of MIMEDX GROUP, INC. (MDXG), acquired 28,609 shares of common stock.
• The transaction occurred on June 18, 2025, with the shares granted at a price of $6.47 per share.
• Following this transaction, Ms. Puhy beneficially owns a total of 57,597 shares of MIMEDX common stock.
• The acquisition represents an annual restricted stock grant to non-employee directors, which is exempt under SEC Rule 16b-3.
• The awarded shares are set to vest upon the earlier of 12 months from the grant date or the next annual meeting of shareholders.

Sentiment

Score: 6

Explanation: The filing reports a routine annual restricted stock grant to a director, which is a standard compensation practice and aligns director interests with shareholders, thus having a neutral to slightly positive sentiment as it reflects ongoing corporate operations.

Positives

• The grant of restricted stock aligns the director's financial interests with those of the shareholders, promoting long-term value creation.
• The transaction is part of a routine, pre-approved compensation plan for non-employee directors, indicating stable corporate governance practices.

Future Outlook

The restricted stock grant is set to vest upon the earlier of 12 months from the grant date or the next annual meeting of shareholders, indicating future ownership for Director Puhy and continued alignment of her interests with the company's long-term performance.

Industry Context

This Form 4 filing details a standard equity compensation event for a non-employee director, a common practice across publicly traded companies in various industries to align director interests with shareholder value and incentivize long-term commitment.

Comparison to Industry Standards

• The grant of restricted stock to a non-employee director is a common compensation practice, aligning with industry standards for corporate governance and incentivizing long-term commitment.
• Companies in the healthcare and biotechnology sectors, such as Stryker Corporation (SYK) or Zimmer Biomet Holdings (ZBH), frequently utilize similar equity-based compensation plans for their non-executive directors, though specific grant sizes and vesting schedules vary based on company size, performance, and compensation policies.

Corporate Governance

Related Party Transactions

• The restricted stock grant to Director Dorothy E. Puhy constitutes a related party transaction as it involves compensation provided to a member of the company's board of directors.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by increasing her equity ownership, potentially fostering decisions that benefit long-term stock performance.
• Management: Reinforces the company's compensation structure for non-employee directors, which is a key aspect of corporate governance.

Next Steps

• Vesting of the restricted stock grant upon the earlier of 12 months from the grant date or the next annual meeting of shareholders.

Key Dates

Recommendation

Keywords

MIMEDX GROUP, MDXG, SEC Form 4, Insider Transaction, Director Compensation, Restricted Stock Grant, Equity Compensation, Corporate Governance